Magouyrk Clayton M.

CEO Magouyrk sells 10,000 ORCL shares at $155.23; stock down 23.2% in 30 days, 27.8% in 90 days.

Magouyrk Clayton M., Chief Executive Officer of Oracle, sold 10,000 shares at $155.23 on 2026-02-09, reducing his holdings from 144,030 to 134,030 shares. The sale came as the stock has declined 23.2% over the prior 30 days and 27.8% over 90 days, trading at $157.16 currently versus a 52-week high of $328.33. Reviewing his same-ticker history at ORCL, 2 of his 3 prior measurable sells were well-timed, with the 2025-10-21 and 2025-09-12 sales followed by 90-day declines of 30.9% and 33.1% respectively, suggesting a pattern of selling before weakness. While current fundamentals remain solid (revenue $16.1B, net income $6.1B, annual growth of 8.4%), the CEO's continued sales during a sustained drawdown—particularly given the demonstrated pattern of prior well-timed exits at this ticker—merit investor attention to whether management views current valuations or near-term catalysts as unfavorable.

CEO Magouyrk sold 10,000 ORCL shares at $192.52 on 2025-12-19 (total $1.9M); stock down -36.7% in 90 days post-sale.

Magouyrk Clayton M., Chief Executive Officer, sold 10,000 shares at $192.52, reducing holdings from 154,030 to 144,030 shares (-6.5%). At the transaction price, the stock has since fallen to $195.34 (current), but critically, the 90-day price action from the sale date through the end of the measurement period shows a -36.7% decline. His prior ORCL sales (three prior trades at this ticker) show mixed timing: the 2025-09-12 sale was well-timed (followed by -33.1% over 90 days), while the 2025-06-17 sale proved poorly timed (+41.1% over 90 days). His cross-ticker track record across all holdings shows 3 prior sells with a 50.00% well-timed rate at the 90-day mark and an average 90d return of +4.0%, indicating his open-market sales have historically lagged market moves by a narrow margin. This sale occurs with the stock -40.5% from its 52-week high of $328.33 and the company trading at a P/E of 36.38 with strong fundamentals (revenue $16.1B, net income $6.1B, +8.4% annual growth).

Oracle CEO Clayton Magouyrk sold 40,000 shares for $11.1M at $276.64 on 2025-10-21; holds 154,030 shares post-sale.

Oracle CEO Clayton Magouyrk sold 40,000 shares (40.0K shares) of ORCL at $276.64 on 2025-10-21 for $11,065,508.00 ($11.1M), reducing his holdings by 20.6% to 154,030 shares (154.0K shares). The sale occurred at a price -14.7% from the 52-week high of $328.33, during a 30-day downtrend of -10.8%. His cross-ticker track record shows prior sells with an average 90-day return of +41.1%, indicating those sales were poorly timed (stock rose after); at Oracle specifically, his prior two sales (2025-09-12 and 2025-06-17) did not establish a pattern of well-timed selling (0 of 1 measurable outcomes were well-timed). The company fundamentals remain solid: $14.9B in latest quarterly revenue, $2.9B net income, and 8.4% annual revenue growth, though the 63.94 P/E suggests premium valuation.

ORCL President Magouyrk sells 21,241 shares at $297.11 for $6.3M; down -15.6% from prior holdings of 136.5K shares

Magouyrk Clayton M., President of OCI at Oracle, sold 21,241 shares on 2025-09-12 at $297.11, reducing holdings from 136,511 to 115,270 shares. The sale reduced his position by 15.6% and realized $6,310,864.66. His single prior ORCL trade on 2025-06-17 (also a sell at the same ticker) posted a 90-day return of +41.1%, indicating the stock rose after that earlier sale—a poorly-timed outcome for an insider seller. Current ORCL trading at $306.65 is up 23.5% over the prior 30 days and up 45.4% over 90 days from the transaction date, placing the shares sold at $297.11 substantially below today's price. With a P/E of 70.01 and market cap of $871.4B supporting recent strong momentum, this sale represents discretionary portfolio activity by a senior executive with a limited track record of poorly-timed sells at this ticker.

ORCL President Clayton Magouyrk sold 15,000 shares at $214.10 on 2025-06-17 (post-sale: 60,722 shares).

Magouyrk sold 15,000 shares (a reduction of -19.8% vs pre-transaction holdings of 75,722 shares) at $214.10, which is 4.7% below the 52-week high of $215.22. The stock has appreciated 30.5% over the last 30 days and 34.8% over the last 90 days. Oracle's fundamentals remain solid with annual revenue growth of +8.4%, net income of $2.9B on revenue of $14.1B, and a market cap of $576.3B, though the P/E of 40.79 reflects a premium valuation. The transaction occurred near the 52-week highs in a period of strong momentum, and the President retains a substantial stake of 60,722 shares post-sale.